Login to Your Account

Clinic Roundup

Friday, November 18, 2011
• Inovio Pharmaceuticals Inc., of Blue Bell, Pa., said a single intradermal electroporation boost of its SynCon avian influenza vaccine generated hemagglutination inhibition (HAI) titers against six different unmatched strains of H5N1, and it generated a fourfold or greater rise in HAI titers in 50 percent of boosted subjects in a Phase I study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription